CS logo
small CS logo
Gazi Universitesi

Besevler Ankara, Turkey

About Gazi Universitesi


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
2
Total Rows: 1

Clinical Trials at Gazi Universitesi


During the past decade, Gazi Universitesi conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails202200.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapsed or Progressed After Treatment With Bortezomib or Are Refractory to Bortezomib. The "EMERGE" Trial
2008-12-22
2017-11-08
Completed
134
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
2022-06-23
2033-01-26
Recruiting
864

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 2Celgene: 2

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Gazi Universitesi


According to Clinical.Site data, the most researched conditions in "Gazi Universitesi" are "Mantle Cell Lymphoma" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Gazi Universitesi" in a lesser frequency.

Clinical Trials Intervention Types at Gazi Universitesi


Most popular intervention types in "Gazi Universitesi" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (1 trials), "Daratumumab" (1 trials), "Dexamethasone" (1 trials), "Iberdomide" (1 trials) and "lenalidomide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Gazi Universitesi


The vast majority of trials in "Gazi Universitesi" are 2 trials for "All" genders.

Clinical Trials Status at Gazi Universitesi


Currently, there are NaN active trials in "Gazi Universitesi". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Gazi Universitesi, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gazi Universitesi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Recruiting: 1Recruiting: 1